Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 27 citing Duttaroy: Development of a long-acting insulin analog using albumin fusion technology. (0.10 sec) 

Albinterferon α-2b: a genetic fusion protein for the treatment of chronic hepatitis C


GM Subramanian, M Fiscella, A Lamousé-Smith, S … - Nature biotechnology, 2007 - nature.com
Treatment regimens based on the use of interferon- (IFN- ) remain the cornerstone of therapy
for chronic hepatitis C virus infection, which affects nearly 170 million people worldwide. Treatment
options include unmodified IFN- given three times weekly or pegylated IFNs given once ...
Cited by 25 - Related articles - BL Direct - All 4 versions

Improved pharmacokinetics of recombinant bispecific antibody molecules by fusion …


D Müller, A Karle, B Meissburger, I Höfig, R Stork, … - Journal of Biological …, 2007 - ASBMB
Recombinant bispecific antibodies such as tandem scFv molecules (taFv), diabodies (Db), or
single chain diabodies (scDb) have shown to be able to retarget T lymphocytes to tumor
cells, leading to their destruction. However, therapeutic efficacy is hampered by a short ...
Cited by 26 - Related articles - All 6 versions

A cocaine hydrolase engineered from human butyrylcholinesterase selectively …


S Brimijoin, Y Gao, JJ Anker, LA Gliddon, … - … official publication of …, 2008 - pubmedcentral.nih.gov
Successive rational mutations of human butyrylcholinesterase (BChE) followed by fusion to human
serum albumin have yielded an efficient hydrolase that offers realistic options for therapy of cocaine
overdose and abuse. This albumin-BChE prevented seizures in rats given a normally ...
Cited by 9 - Related articles - All 4 versions

Newer insulin analogues and inhaled insulin


C Girish, S Manikandan, M Jayanthi - Indian Journal of Medical Sciences, 2006 - Medknow
Diabetes is a metabolic disease with high prevalence worldwide. Exogenous insulin is used
in the management of this condition. The development of human insulin has provided tighter
control of glycaemia in diabetic patients. Insulin analogues like insulin lispro and aspart ...
Cited by 8 - Related articles - Cached - All 6 versions

Prolonged in-vivo half-life of factor VIIa by fusion to albumin.


T Weimer, W Wormsbächer, U Kronthaler, W … - Thrombosis and …, 2008 - ncbi.nlm.nih.gov
For the treatment of haemophilia patients with inhibitors, recombinant factor VIIa (rFVIIa) is available
as a therapeutic option to control bleeding episodes with a good balance of safety and
efficacy. However, the short in-vivo half-life of approximately 2.5 hours makes multiple ...
Cited by 7 - Related articles - BL Direct - All 3 versions

Preparation and characterization of a novel exendin-4 human serum albumin …


YS Huang, Z Chen, YQ Chen, GC Ma, JF … - Journal of Peptide …, 2008 - interscience.wiley.com
A novel recombinant exendin-4 human serum albumin fusion protein (rEx-4/HSA) expressed
in Pichia pastoris was prepared and characterized. Ex-4 is a 39-amino acid peptide isolated
from the salivary gland of the lizard Heloderma suspectum and is thought to be a novel ...
Cited by 7 - Related articles - BL Direct - All 3 versions

Extending half-life in coagulation factors: where do we stand?


D Lillicrap - Thrombosis Research, 2008 - Elsevier
The human coagulation factor VIII (FVIII) and von Willebrand factor (VWF) are two distinct glycoproteins
that circulate in the plasma as a non-covalently bound complex (VWF/FVIII complex). Deficiencies
or structural defects in FVIII and VWF are responsible for the most common inherited ...
Cited by 2 - Related articles - All 5 versions

Preparation and Characterization of Monopegylated Human Granulocyte- …


DL Lee, I Sharif, S Kodihalli, DIH Stewart, V … - Journal of Interferon & …, 2008 - liebertonline.com
Conjugates of recombinant human granulocyte-macrophage colony-stimulating factor
(GM-CSF) attached to polyethylene glycol (PEG) chains were prepared using amine-reactive
chemistry. Molecular masses of the PEGs were 20, 30, and 40 kDa. The monopegylated ...
Cited by 1 - Related articles - BL Direct - All 4 versions

Advances and challenges in developing cytokine fusion proteins as improved …


CH Chang, P Gupta, DM … - Expert Opinion on Drug …, 2009 - informahealthcare.com
Background: Recombinant forms of natural proteins with therapeutic potential rarely make ideal
pharmaceuticals. Fusion of these proteins to human serum albumin, human transferrin, the constant
region fragment of a human IgG or a desirable antibody to improve their bioavailability, ...
Cited by 1 - Related articles - All 5 versions

Single-Chain Insulins as Receptor Agonists


G Rajpal, M Liu, Y Zhang, P Arvan - Molecular Endocrinology, 2009 - Endocrine Soc
Single-chain insulins (SCIs) are single polypeptide chains in which the insulin B-chain links contiguously
with the insulin A-chain via an uncleaved connecting peptide. Although direct linkage of insulin
B- and A-chains produces SCIs with little insulin receptor binding, biologists have been ...
Related articles - All 4 versions


Result Page: 

1

2

3

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google